Homeopathic teething products may harm infants: FDA

Image
IANS Washington
Last Updated : Oct 01 2016 | 1:57 PM IST

Homeopathic teething tablets and gels may pose a health risk to infants and children, the US Food and Drug Administration (FDA) has warned.

Consumers should stop using these products and dispose of any in their possession, FDA recommended on Friday.

Homeopathic teething tablets and gels are distributed by CVS, Hyland's, and possibly others, and are sold in retail stores and online, the US drug regulator said in a statement.

Following the FDA's warning, CVS announced a voluntary withdrawal of all brands of homeopathic teething products sold in its retail stores and online at CVS.com.

"Consumers should seek medical care immediately if their child experiences seizures, difficulty breathing, lethargy, excessive sleepiness, muscle weakness, skin flushing, constipation, difficulty urinating, or agitation after using homeopathic teething tablets or gels," FDA said.

"Teething can be managed without prescription or over-the-counter remedies," said Janet Woodcock, Director of the FDA's Center for Drug Evaluation and Research.

"We recommend parents and caregivers not give homeopathic teething tablets and gels to children and seek advice from their health care professional for safe alternatives," Woodcock noted.

The FDA is analysing adverse events reported to the agency regarding homeopathic teething tablets and gels, including seizures in infants and children who were given these products, since a 2010 safety alert about homeopathic teething tablets.

The FDA is currently investigating this issue, including testing product samples.

--IANS

gb/vm

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 01 2016 | 1:48 PM IST

Next Story